-
4 days ago | 
pharmacytimes.com | Kennedy Ferruggia
Clarity Breast, a novel, image-based prognostic platform designed to predict 5-year breast cancer risk from a routine screening mammogram, has received FDA de novo authorization, advancing precision medicine to transform breast cancer care.1“For more than 60 years, mammograms have saved lives by detecting early-stage cancers.
-
4 days ago | 
pharmacytimes.com | Kennedy Ferruggia |Mike Cohn
CommentaryVideoJune 3, 2025Author(s):,Electronic prior authorization (EPA) technology can streamline the complex process of obtaining prior authorizations for GLP-1 medications. In an interview with Pharmacy Times®, Mike Cohn, vice president of network operations at CoverMyMeds, explored the challenges in the prior authorization process for glucagon-like peptide-1 (GLP-1) medications.
-
4 days ago | 
pharmacytimes.com | Joshua K. Sabari |Kennedy Ferruggia
At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Joshua Sabari, MD, assistant professor of medicine and medical oncology at Perlmutter Cancer Center NYU Langone Health, presented data that examined the development of zongertinib (BI 1810631; Boehringer Ingelheim), a HER2-selective tyrosine kinase inhibitor (TKI) for the treatment of HER2-mutant advanced non-small cell lung cancer (NSCLC).
-
5 days ago | 
pharmacytimes.com | Kennedy Ferruggia
The FDA has granted interchangeability designation to Hadlima (adalimumab-bwwd; Samsung Bioepis, Organon), a biosimilar to Humira (adalimumab; AbbVie), as a high- and low-concentration autoinjector and a high-concentration prefilled syringe.1“Hadlima, now designated as fully interchangeable with the reference product, has a greater potential to bring savings for patients.
-
1 week ago | 
pharmacytimes.com | Kennedy Ferruggia
Author(s):The FDA grants fast track designation to TEV-53408, a promising treatment for celiac disease designed to address gluten intolerance and improve patient outcomes.
-
1 week ago | 
pharmacytimes.com | Kennedy Ferruggia
Vitamin B12 Levels Within Normal Range Are Linked to Cognitive Decline in Older AdultsThe current minimum vitamin B12 recommendations may be insufficient for older adults, with new research revealing that cognitive impairment was linked to levels within the normal range.1,2The current recommended daily amount of vitamin B12 for adults is 2.4 μg, which is often obtained through diet.
-
1 week ago | 
pharmacytimes.com | Kennedy Ferruggia
Respiratory viral infections (RVIs) are known to increase cardiovascular risk, yet the specific cardiac complications associated with respiratory syncytial virus (RSV) compared with other common vaccine-preventable RVIs like COVID-19 or influenza have remained unclear.
-
1 week ago | 
pharmacytimes.com | Kennedy Ferruggia
The FDA has approved an expanded indication of the quadrivalent meningococcal vaccine (MenQuadfi; Sanofi Pasteur Inc.) for the prevention of invasive meningococcal disease in children aged 6 weeks to 23 months.1 “Meningococcal meningitis remains a major global health challenge because it can strike quickly and with devastating effect, taking a life in less than 24 hours,” David Loew, executive vice president of Sanofi Pasteur, said in a news release.2 MenQuadfi is indicated as a single 0.5 mL...
-
1 week ago | 
pharmacytimes.com | Kennedy Ferruggia |Mike Cohn
CommentaryVideoMay 27, 2025Author(s):,The expert explored the complex prior authorization process for GLP-1 medications, discussing challenges in documentation and medical necessity.
-
2 weeks ago | 
pharmacytimes.com | Kennedy Ferruggia
New study results announced by Eli Lilly and Company demonstrated promising topline results for orforglipron (Eli Lilly and Company), a novel oral glucagon-like peptide-1 (GLP-1) receptor agonist used to treat adults with type 2 diabetes (T2D) and inadequate glycemic control with diet and exercise.1 Understanding Orforglipron Orforglipron is a nonpeptide GLP-1 receptor agonist that functions by stimulating insulin release from the pancreas and slowing gastric emptying, which can promote...
